Today we highlight research findings reported at ESMO 2024, the annual meeting of the European Society of Medical Oncology.

Bowers added that to increase access to the latest drugs, the "cancer system" must be organized in such a way as to ...

Before the annual congress of the European Society for Medical Oncology began in Barcelona, clinicians held a press ...

From combining treatments in unprecedented ways to deploying artificial intelligence for personalized medicine, a raft of new ...

High response rates reported by GSK and iTeos at the 2024 European Society for Medical Oncology Congress offer a ray of light ...

Breastfeeding is feasible for patients with hormone receptor–positive breast cancer who are undergoing a break of endocrine ...

SOLARIS (Alliance A021703), a multicenter, double-blind, randomized Phase III clinical trial led by Dana-Farber Cancer ...

Wall Street apparently wanted more from Prelude Therapeutics Inc.’s phase I data with SMARCA2 enzyme degrader PRT-3789 in ...

Metastatic solid tumors may be curable now. Among the most profound results presented over the weekend at the European ...

CG Oncology stock is up 7% following bladder cancer data released by Johnson & Johnson. Read more here.

For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant ...